top of page
Sensirion_edited.jpg

Year:

2018

Vertical:

Health & Nutrition

Ranking:

Top 5

Araris

Araris develops antibody-drug conjugates (ADCs) for targeted cancer therapy. Generating ADCs with current methods is complex and expensive, and they often have limited stability and suboptimal efficacy. Without engineering, we can turn any native antibody into an ADC with optimal properties.

2000_W1_Carbofix.png
bottom of page